micronized titanium dioxide suppliers
Peintures et revêtements : il convient pour une utilisation dans les mastics et dans les compositions des produits de jointoiement et d'étanchéité.
The manufacturing of titanium dioxide typically begins with the extraction of titanium ore from mines. The most common method for producing titanium dioxide involves two main processes the sulfate process and the chloride process. Each has its advantages and disadvantages, but both aim to transform raw titanium ore into high-purity titanium dioxide.
The accuracy of the gravimetric analysis factory is crucial in ensuring the quality of the titanium dioxide products produced. By accurately measuring the amount of titanium dioxide present in a sample, the factory can guarantee the purity and consistency of the final product. This is especially important in industries such as cosmetics, where the color and consistency of products are key factors in consumer satisfaction.
On November 23, 2022, the General Court of the European Union reversed the conclusion that titanium dioxide was carcinogenic and released a statement (1,2):
“First, the Commission made a manifest error in its assessment of the reliability and acceptability of the study on which the classification was based and, second, it infringed the criterion according to which that classification can relate only to a substance that has the intrinsic property to cause cancer.”
As part of our mission at CRIS we base our safety assessments on the currently available scientific evidence and consider many variables (e.g., study quality, journal of publication, etc.), even if it goes against previous conclusions. Evidence-informed decisions making is critical to ensure that the laws and regulations put into place are for the benefit of the population.
The EU General Court maintains that the scientific evidence presented wasn’t the complete picture for the ingredient, “in the present case, the requirement to base the classification of a carcinogenic substance on reliable and acceptable studies was not satisfied.”
“First, the Commission made a manifest error in its assessment of the reliability and acceptability of the study on which the classification was based and, second, it infringed the criterion according to which that classification can relate only to a substance that has the intrinsic property to cause cancer.”
As part of our mission at CRIS we base our safety assessments on the currently available scientific evidence and consider many variables (e.g., study quality, journal of publication, etc.), even if it goes against previous conclusions. Evidence-informed decisions making is critical to ensure that the laws and regulations put into place are for the benefit of the population.
The EU General Court maintains that the scientific evidence presented wasn’t the complete picture for the ingredient, “in the present case, the requirement to base the classification of a carcinogenic substance on reliable and acceptable studies was not satisfied.”